Skip to main content
Filing year 2023

THE CHOLANGIOCARCINOMA FOUNDATION

Salt Lake City, Utah·EIN 20-5776861·NTEE H99 · Medical Research·3
Total revenue
$6.9M
Total assets
$6M
Total expenses
$6.2M
Reported officers
14
Mission

THE ORGANIZATION'S MISSION IS TO FIND A CURE AND IMPROVE THE QUALITY OF LIFE FOR CHOLANGIOCARCINOMA PATIENTS.

Executive compensation, broken down

Form 990 · Schedule J · 4 reported individuals · Filing year 2023

Ceo/founder
officer (unspecified)
$210k
$230k
Base
$186k
Bonus
$16k
Other
Benefits
$4k
Base
$150k
Bonus
Other
Benefits
$6k
Base
$142k
Bonus
$11k
Other
Benefits
$2k
CPO
highest compensated employee
$107k
$117k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the West region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 10 unpaid individuals.

Browse compensation in Medical Research

Sector benchmark

What Medical Research executives earn

Comparable medical research organizations nationwide pay their highest-earning executive a median of $114,840.

25th percentile
$40k
Median
$114,840
75th percentile
$234k
90th percentile
$424k

These are medical research sector-wide figures, not this organization's reported pay. Based on 283 organizations across 283 filings (2021 – 2023).

See full Medical Research compensation data
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.